Ipilimumab and nivolumab: the ‘new kid on the block’ in advanced angiosarcoma

Immunotherapy, Ahead of Print.

Source: Immunotherapy - August 10, 2023 Category: Allergy & Immunology Authors: Tarek Assi Rebecca Ibrahim Toni Ibrahim Rita Khoury Axel Le Cesne Source Type: research